id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4000-0031,FDA,FDA-2018-N-4000,"Framework for a Real-World Evidence Program; Availability; Reopening of
the Comment Period",Notice,Request for Comments,2019-02-15T05:00:00Z,2019,2,2019-02-15T05:00:00Z,2019-04-17T03:59:59Z,2019-04-17T01:03:32Z,2019-02561,0,0,0900006483a7a5dc
FDA-2018-N-4000-0001,FDA,FDA-2018-N-4000,Framework for a Real-World Evidence Program; Availability,Notice,Notice of Availability,2018-12-07T05:00:00Z,2018,12,2018-12-07T05:00:00Z,2019-02-06T04:59:59Z,2024-11-12T22:49:40Z,2018-26546,1,0,0900006483958758